204 related articles for article (PubMed ID: 14071282)
1. [METHODS AND RESULTS OF PREPARATION OF LIVE POLIOMYELITIS VACCINE, NOT CONTAINING MIXTURES OF VACUOLIZING VIRUS (OB40-SV40)].
CHUMAKOV MP; DZAGUROV SG; LASHKEVICH VA; GRACHEV VP; MIRONOVA LL; RALF NM; ELBERT LB
Vopr Virusol; 1963; 29():445-9. PubMed ID: 14071282
[No Abstract] [Full Text] [Related]
2. [DETECTION OF ANTIBODIES TO MONKEY VIRUS (OB40) IN HUMAN SERA. SEROLOGICAL EVIDENCE OF INFECTION FROM MONKEYS AND KIDNEY CULTURES].
CHUMAKOVA MIa; CHUMAKOV MP; ELBERT LB; AVGUSTINOVICH GI; RALF NM; VOROSHILOVA MK; TARANOVA GP; TAPUPERE VO
Vopr Virusol; 1963; 29():457-60. PubMed ID: 14071285
[No Abstract] [Full Text] [Related]
3. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
GUENTHER O; HOEVEL H; VON METTENHEIM
Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
[No Abstract] [Full Text] [Related]
4. [THE MONKEY VIRUS SV 40 IN POLIOMYELITIS VACCINE TESTS].
GUENTHER O; HOEVEL H; VON METTENHEIM
Zentralbl Bakteriol Orig; 1963 Dec; 191():83-9. PubMed ID: 14119946
[No Abstract] [Full Text] [Related]
5. [VIROLOGICAL AND SEROLOGICAL DATA ON LATENT INFECTION CAUSED BY OB40 (SV40) VIRUS IN MACACA RHESUS MONKEYS].
KOLIASKINA GI
Vopr Virusol; 1963; 29():450-2. PubMed ID: 14071283
[No Abstract] [Full Text] [Related]
6. [ELECTRON MICROSCOPE EXAMINATION OF VACUOLIZING VIRUS OB40 IN GRIVET MONKEY KIDNEY CELL TISSUE CULTURE AND IN VIRUS SUSPENSIONS].
SHESTOPALOVA NM; REINGOLD VN; KOLIASKINA GI; CHUMAKOV MP
Vopr Virusol; 1963; 29():466-70. PubMed ID: 14071286
[No Abstract] [Full Text] [Related]
7. [USE OF THE FLUORESCENT ANTIBODY TECHNIC FOR STUDY OF THE LOCALIZATION OF SIMIAN VIRUS NO. 40 IN THE CELL AND FOR ITS RAPID DETECTION IN VACCINE].
DZAGUROV SG; CHUMAKOV MP; KARMYSHEVA VIa; KOLIASKINA GI; GRAEVSKAIA NA; KUROCHKINA NP; PANOSIAN LB
Vopr Virusol; 1963; 29():471-4. PubMed ID: 14071287
[No Abstract] [Full Text] [Related]
8. INTRATYPIC SERODIFFERENTIATION TESTS ON POLIO TYPE 1 VIRUS STRAINS ISOLATED BEFORE AND AFTER VACCINATION WITH ATTENUATED SABIN TYPE 1 POLIO VACCINE.
HAHNEMANN F; SIBONI K; GODTFREDSEN A
Acta Pathol Microbiol Scand; 1964; 61():437-45. PubMed ID: 14164891
[No Abstract] [Full Text] [Related]
9. Serum inhibition of cytopathic effect and virus release of type 3 poliovirus vaccine in primary monkey-kidney (MK) cultures.
ORSI EV; MESSORE G; LEVINE S; ROCA-GARCIA M
Am J Hyg; 1961 May; 73():282-93. PubMed ID: 13731294
[No Abstract] [Full Text] [Related]
10. [CYTOLOGICAL AND CYTOCHEMICAL EXAMINATION OF PRIMARY AND CONTINUOUS KIDNEY CELL CULTURES OF THE AFRICAN GRIVET MONKEY (CERCOPITHECUS AETHIOPS) INFECTED WITH SIMIAN VIRUS OB40].
KARMYSHEVA VIa; SHESTOPALOVA NM; REINGOLD VN; KOLIASKINA GI; CHUMAKOV MP
Vopr Virusol; 1963; 18():460-6. PubMed ID: 14074924
[No Abstract] [Full Text] [Related]
11. [STUDIES ON TESTS FOR THE NON-TOXICITY OF INACTIVATED POLIOMYELITIS VACCINES. 1. INFLUENCE OF MAGNESIUM CHLORIDE ON THE SUSCEPTIBILITY OF MONKEY KIDNEY CELL CULTURES TO FORMALIN-TREATED POLIOMYELITIS VIRUS].
GUENTHER O; HOEVEL H; VON METTENHEIM
Zentralbl Bakteriol Orig; 1963 Nov; 190():313-21. PubMed ID: 14105973
[No Abstract] [Full Text] [Related]
12. Experience with preparation an laboratory control of oral poliomyelitis vaccine in Czechoslovakia.
SLONIM D; MARES I; DREVO M; STURMOVA H; SIMON J
Bull World Health Organ; 1962; 26(3):331-9. PubMed ID: 13913913
[TBL] [Abstract][Full Text] [Related]
13. MARKER TEST OF POLIOVIRUS IN RELATION TO MASS VACCINATION WITH LIVE ORAL VACCINES.
TOYOSHIMA K; MITSUDA B; TADOKORO J; YAMADA T; KUNITA N
Biken J; 1963 Jul; 6():57-72. PubMed ID: 14147706
[No Abstract] [Full Text] [Related]
14. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
GUENTHER O; VON METTENHEIM ; HOEVEL H
Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847
[No Abstract] [Full Text] [Related]
15. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. I. STUDIES ON TYPE 1 STRAINS.
FURESZ J; ARMSTRONG RE; YAROSH W; NAGLER FP
Am J Hyg; 1964 Jul; 80():45-54. PubMed ID: 14192769
[No Abstract] [Full Text] [Related]
16. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS.
FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP
Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770
[No Abstract] [Full Text] [Related]
17. [WHAT DOES THE TESTING OF VIRAL VACCINES DO FOR THE HARMLESSNESS OF VACCINES IN THEIR PRACTICAL USE?].
BONIN O; GUENTHER O
Med Welt; 1964 Apr; 15():822-31. PubMed ID: 14194499
[No Abstract] [Full Text] [Related]
18. [ULTRASTRUCTURAL STUDY OF THE DEVELOPMENT OF A LATENT SIMIAN VIRUS].
GRANBOULAN N; WICKER R
C R Hebd Seances Acad Sci; 1963 Jul; 257():1194-6. PubMed ID: 14054219
[No Abstract] [Full Text] [Related]
19. [ANTIBODIES TO OB40 (SV40) IN MONKEYS OF DIFFERENT SPECIES].
CHUMAKOVA MIa; AVGUSTINOVICH GI; ZABODOVA TI
Vopr Virusol; 1963; 29():452-6. PubMed ID: 14071284
[No Abstract] [Full Text] [Related]
20. Live oral poliovirus vaccines do not contain detectable simian virus 40 (SV40) DNA.
Sierra-Honigmann A; Krause PR
Biologicals; 2000 Mar; 28(1):1-4. PubMed ID: 10799049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
